We are a financial services provider for several types of professional clients, each with distinct needs.
ABI's organic volume growth has been negative in 2023 and 2024E. Whilst part of the poor volume performance stems from the US Bud Light woes, we wonder what the role of price elasticity and structural changes in consumer habits might be and decided to lower our structural volume growth forecast until the end of the decade to only 1%. Taking into account persistent negative FX headwinds, we forecast a 3.5% adjusted EBITDA CAGR until 2030, or +4% on an organic basis (at the low end of the mid term...
Due to the ongoing inventory correction, automotive and industrial chip companies like Melexis are currently under-shipping relative to their end-demand levels. This has led to temporarily depressed sales and gross margins. However, we expect their earnings to rebound into 2H25E and FY26. We anticipate that the stock market will look beyond the current weakness and begin pricing in the higher FY26E earnings levels over the next 4 quarters. Melexis is currently experiencing most of its weakness f...
Rising interest rates are becoming a hot topic, triggered by a significant uptick in US 10-year treasury yields through February and March. In this note we revisit this topic from several angles. We dig into the empirical side of what we can reasonably expect from the market as a whole when interest rates start to rise. Secondly we review our coverage, putting forward a number of impacted sectors and stocks.